Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Tafenoquine bulk supplier for pharma manufacturers

Tafenoquine 100mg, 150mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100mg, 150mg

Reference Brands: Arakoda (USA), Krintafel(USA)

Category: Anti Viral

Tafenoquine is an antimalarial drug used for the treatment and prevention of Plasmodium vivax malaria. It belongs to the 8-aminoquinoline class and works by eliminating dormant liver stages of the parasite to prevent relapse. Tafenoquine is available as oral tablets and marketed under brand names Krintafel (treatment) and Arakoda (prophylaxis). It is placed under Critical Care for specialty infectious disease management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Tafenoquine — third party manufacturing & bulk supply

Tafenoquine 100mg, 150mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Tafenoquine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Tafenoquine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Tafenoquine is used for the radical cure and prevention of malaria caused by Plasmodium vivax. It helps eliminate dormant liver-stage parasites (hypnozoites) to prevent relapse and is also used for malaria prophylaxis in travelers. It offers a long-acting alternative to traditional regimens like primaquine.

Tafenoquine is a synthetic 8-aminoquinoline antimalarial compound. It works by generating oxidative stress within the parasite, disrupting essential cellular processes and eliminating both blood-stage and liver-stage forms of the malaria parasite.

Tafenoquine is marketed under the trade names Krintafel for radical cure of P. vivax and Arakoda for malaria prophylaxis.

Krintafel and Arakoda are manufactured by GlaxoSmithKline (GSK) in partnership with the Medicines for Malaria Venture (MMV). Arakoda for prophylaxis is also distributed by 60 Degrees Pharmaceuticals.

The generic name of the product is tafenoquine.

Common brand names include Krintafel and Arakoda.

Tafenoquine (Krintafel and Arakoda) is manufactured in GSK’s approved global facilities and distributed through licensed pharmaceutical partners. Production for prophylaxis formulations may also involve 60 Degrees Pharmaceuticals under regulatory authorization.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.